-+ 0.00%
-+ 0.00%
-+ 0.00%

KURA ONCOLOGY REPORTS DURABLE CLINICAL ACTIVITY OF DARLIFARNIB PLUS CABOZANTINIB IN CABOZANTINIB-NAÏVE CLEAR CELL RENAL CELL CARCINOMA PATIENTS AT KCRS 2026

路透·07/27/2026 10:32:00

登錄查看新聞詳情